Share Twitter LinkedIn Facebook Email Rita Sanghvi Mehta, MD, UC Irvine Health, talks about Improving Survival in Stage 4 Breast Cancer | S0226 Showed That Patients Could Have Improved Survival at MOASC 2018.
Atezolizumab Stumbles in Triple Negative Breast Cancer Study: SABCS 2024 Results with Charles Geyer Breast 4 Mins Read